Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
55
UHS Quote, Financials, Valuation and Earnings
Last price:
$226.94
Seasonality move
:
9.03%
Day range:
$225.47 - $229.15
52-week range:
$152.33 - $246.33
Dividend yield:
0.35%
P/E ratio:
10.79x
P/S ratio:
0.87x
P/B ratio:
1.98x
Volume:
171K
Avg. volume:
709.1K
1-year change:
25.31%
Market cap:
$14.2B
Revenue:
$15.8B
EPS (TTM):
$21.04
Analysts' Opinion
-
Consensus RatingUniversal Health Services, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 7 Buy ratings, 9 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $252.18, Universal Health Services, Inc. has an estimated upside of 11.05% from its current price of $227.08.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $190.00 representing 100% downside risk from its current price of $227.08.
Fair Value
-
According to the consensus of 16 analysts, Universal Health Services, Inc. has 11.05% upside to fair value with a price target of $252.18 per share.
UHS vs. S&P 500
-
Over the past 5 trading days, Universal Health Services, Inc. has underperformed the S&P 500 by -0.45% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Universal Health Services, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Universal Health Services, Inc. has grown year-over-year revenues for 21 quarters straight. In the most recent quarter Universal Health Services, Inc. reported revenues of $4.5B.
Earnings Growth
-
Universal Health Services, Inc. has grown year-over-year earnings for 8 quarters straight. In the most recent quarter Universal Health Services, Inc. reported earnings per share of $5.86.
Enterprise value:
19.3B
EV / Invested capital:
1.56x
Price / LTM sales:
0.87x
EV / EBIT:
9.91x
EV / Revenue:
1.14x
PEG ratio (5yr expected):
0.27x
EV / Free cash flow:
19.95x
Price / Operating cash flow:
15.35x
Enterprise value / EBITDA:
7.57x
Gross Profit (TTM):
$1.9B
Return On Assets:
9.41%
Net Income Margin (TTM):
8.24%
Return On Equity:
20.13%
Return On Invested Capital:
11.66%
Operating Margin:
11.61%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $14B | $15.4B | $17B | $4B | $4.5B | |
| Gross Profit | $1.1B | $1.5B | $1.9B | $384.2M | $521.7M | |
| Operating Income | $1.1B | $1.5B | $1.9B | $384.2M | $521.7M | |
| EBITDA | $1.7B | $2.1B | $2.6B | $533.7M | $676.7M | |
| Diluted EPS | $9.53 | $15.03 | $21.04 | $3.80 | $5.86 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.3B | $2.5B | $2.8B | $2.8B | $3.3B | |
| Total Assets | $12.8B | $13.4B | $13.9B | $14.4B | $15.3B | |
| Current Liabilities | $2B | $1.9B | $2B | $2B | $3.2B | |
| Total Liabilities | $6.5B | $7.5B | $7.8B | $7.7B | $8B | |
| Total Equity | $6.4B | $5.9B | $6.1B | $6.7B | $7.3B | |
| Total Debt | $4B | $5.1B | $5.3B | $5B | $5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.1B | $1.9B | $1.9B | $333M | $380.7M | |
| Cash From Investing | -$772.2M | -$942M | -$1.1B | -$265.6M | -$269.4M | |
| Cash From Financing | -$327.6M | -$900.4M | -$880.4M | -$89.7M | -$134.5M | |
| Free Cash Flow | $411.6M | $956.8M | $968.3M | $85M | $151.8M | |
UHS
Sector
Market Cap
$14.2B
$28M
Price % of 52-Week High
92.19%
51.03%
Dividend Yield
0.35%
0%
Shareholder Yield
6.75%
-1.54%
1-Year Price Total Return
25.31%
-17.48%
Beta (5-Year)
1.272
0.518
Dividend yield:
0.35%
Annualized payout:
$0.80
Payout ratio:
3.41%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$225.58
200-day SMA
Buy
Level
$192.23
Bollinger Bands (100)
Buy
Level
185.64 - 227.16
Chaikin Money Flow
Buy
Level
1.3M
20-day SMA
Sell
Level
$229.19
Relative Strength Index (RSI14)
Buy
Level
51.09
ADX Line
Buy
Level
13.25
Williams %R
Neutral
Level
-43.8793
50-day SMA
Buy
Level
$224.27
MACD (12, 26)
Buy
Level
59.67
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
1.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.0476)
Buy
CA Score
(Annual)
Level (0.1983)
Buy
Beneish M-Score
(Annual)
Level (-2.7232)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-1.0236)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Universal Health Services, Inc. engages in providing hospital and healthcare services. It operates through the following segments: Acute Care Hospital Services, Behavioral Health Care Services, and Other. The Acute Care Hospital Services segment includes hospitals, freestanding emergency departments, and ambulatory centers. The Behavioral Health Care Services segment offers treatment programs for depression, anxiety, psychotic diagnoses, bipolar disorder, post-traumatic stress disorder, and neurorehabilitation. The Other segment consists of centralized services such as information technology, purchasing, reimbursement, accounting and finance, taxation, legal, advertising, and design and construction. The company was founded by Alan B. Miller in 1979 and is headquartered in King of Prussia, PA.
Stock Forecast FAQ
In the current month, UHS has received 7 Buy ratings 9 Hold ratings, and 0 Sell ratings. The UHS average analyst price target in the past 3 months is $252.18.
-
Where Will Universal Health Services, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Universal Health Services, Inc. share price will rise to $252.18 per share over the next 12 months.
-
What Do Analysts Say About Universal Health Services, Inc.?
Analysts are divided on their view about Universal Health Services, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Universal Health Services, Inc. is a Sell and believe this share price will drop from its current level to $190.00.
-
What Is Universal Health Services, Inc.'s Price Target?
The price target for Universal Health Services, Inc. over the next 1-year time period is forecast to be $252.18 according to 16 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 9 analysts rate the stock a Hold.
-
Is UHS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Universal Health Services, Inc. is a Hold. 9 of 16 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of UHS?
You can purchase shares of Universal Health Services, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Universal Health Services, Inc. shares.
-
What Is The Universal Health Services, Inc. Share Price Today?
Universal Health Services, Inc. was last trading at $226.94 per share. This represents the most recent stock quote for Universal Health Services, Inc.. Yesterday, Universal Health Services, Inc. closed at $227.08 per share.
-
How To Buy Universal Health Services, Inc. Stock Online?
In order to purchase Universal Health Services, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get UHS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
UHS
Sector
P/E ratio
10.79x
23.89x
PEG ratio
0.27x
-0.01x
P/B ratio
1.98x
1.82x
Price / LTM sales
0.87x
1.60x
Growth Metrics
UHS
Sector
Revenue growth
13.43%
4.62%
Earnings growth
54.22%
10.88%
Revenue (5-year growth)
6.82%
6.5%
Earnings forecast
$4.95
-$0.21
Profitability
UHS
Sector
Profitability FY 2024
$1.7B
$3.5M
Return on invested capital
11.66%
-31.77%
Return on assets
9.41%
-27.96%
Return on equity
20.13%
-37.63%
Earnings Date
Last Earnings Date
Oct
27
Next Earnings Date
Feb
25
Estimated Next Earnings Date
Jan
26
Balance Sheet
UHS
Sector
Total cash
$112.9M
$26.3M
Short term investments
--
$25.7M
Total assets
$14.9B
$78M
Long term debt
$5B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
